Navigation Links
Study details paired risk factors in preeclampsia
Date:9/10/2013

PROVIDENCE, R.I. [Brown University] Although preeclampsia occurs in about 3 percent of pregnancies, it's still unforeseen in many cases. A report of new research, now in press at the Journal of Reproductive Immunology, documents how two distinct risk factors combine to affect the odds that a first-time mother could develop the sometimes life-threatening pregnancy complication. The findings suggest there could be new ways to plan pregnancy with improved awareness and management of the risk.

For years evidence has mounted that preeclampsia may have its origin in the mother's immune response to pregnancy. For that reason, researchers have been studying the potential role of two risk factors: the level of similarity between the mother and father or mother and fetus in a set of five human leukocyte antigen (HLA) genes related to immune system compatibility; and the degree of vaginal exposure the mother has had to the father's semen before becoming pregnant.

The new study, first published online in August, measured both of those risk factors in detail and in combination in 118 women who developed preeclampsia and in 106 similar women who did not. The data set came from SOPHIA, the Study of Pregnancy Hypertension in Iowa maintained by the University of Iowa.

The study's main finding is that women who have had relatively little prior vaginal exposure to the father's semen and who had a high-level of matching of the class I group of three HLA genes had 4.5 times greater odds of developing preeclampsia than women with greater exposure and less gene matching. The analysis accounted for other risk factors, such as Body Mass Index.

"When you have both low seminal fluid exposure and high sharing [of Class I HLA genes], you are at highest risk," said study lead and corresponding author Elizabeth Triche, assistant professor of epidemiology in Brown University's School of Public Health.

The increased odds appear to confirm pr
'/>"/>

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. African-American study identifies 4 genetic variants associated with blood pressure
2. Therapy slows onset and progression of Lou Gehrigs disease, study finds
3. Cytos Biotechnology Presents Additional Results From Phase 2a Study of CYT003 for the Treatment of Allergic Asthma
4. LSUHSC researchers develop new system to better study behavior, cell function
5. 400-year study finds Northeast forests resilient, changing
6. UCSF receives $4.5M to study value of gene sequencing in newborns
7. First study to investigate the human genome in multiple sclerosis
8. Red cedar tree study shows that Clean Air Act is reducing pollution, improving forests
9. Penn study: Shutting off neurons helps bullied mice overcome symptoms of depression
10. Type 2 diabetes study to examine role amylin plays in disease
11. Cell study offers more diabetic patients chance of transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2014)... Nov. 5, 2014 – University of Utah engineers developed ... help jet fuel produce electricity without needing to ignite ... to power portable electronics, off-grid power and sensors. , ... in the American Chemical Society journal ACS Catalysis ... a chemical reaction between a fuel and an oxygen-rich ...
(Date:11/4/2014)... of Medicine announced today that it is a ... the Bill & Melinda Gates Foundation. Laura ... Reproductive Sciences; and Vice Chair of Research and ... will pursue an innovative global health and development ... Fetal Neurodevelopment.", Grand Challenges Explorations (GCE) funds individuals ...
(Date:11/4/2014)... published research study examining only marketing directed at ... food restaurants has found that the majority of ... to such marketing tactics. , Authored by Arizona ... the study is the first to examine the ... exterior of fast food restaurants and its relationship ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Temple University School of Medicine receives Grand Challenges Explorations grant 2Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3
... helped make genome sequencing much more common than in the ... different sequencing methods and the best ways to evaluate these ... measure the validity of genome sequencing. The method, which ... for the evaluation of a wide range of genome sequencing ...
... fish from Lake Victoria are described by ... and the Institute of Biology Leiden (Section Integrative ... in honour of Tijs Goldschmidt , author of ... the dramatic extinction of hundreds of cichlid species in Lake ...
... temperatures below freezing with antifreeze proteins. How the larva ... withstand temperatures down to -30 degrees Celsius is reported ... Dr. Martina Havenith from the Department of Physical Chemistry ... . Together with American colleagues, the RUB-researchers showed that ...
Cached Biology News:Researchers develop tool to evaluate genome sequencing method 2A new fish species from Lake Victoria named in honor of the author of Darwin's Dreampond 2Dance of water molecules turns fire-colored beetles into antifreeze artists 2
(Date:11/24/2014)... 24, 2014   ...   Elsevier , a world-leading provider of ... to announce the launch of the latest title in the ... Opinion in Food Science . ... with a new platform to keep up-to-date with the expanding ...
(Date:11/24/2014)... Billerica, Massachusetts (PRWEB) November 24, 2014 ... Simplify Panels ” from METTLER TOLEDO demonstrates how ... panel. , Power analytics and sample panel design ... control cycle chemistry and protect against corrosion and ... take up a significant amount of panel space. ...
(Date:11/22/2014)... November 21, 2014 During his lifetime ... the need to surround himself with great people and ... entrepreneur, his friends often marveled at his extraordinarily courageous ... his life and -- even with his death impending—that’s ... Alzheimer’s disease that would ultimately take his life. , ...
(Date:11/22/2014)... The “Chiral Chromatography Columns Market ... (Metal, Glass, Plastic), by Application [GC, LC (HPLC, ... to 2018” analyses and studies the major market ... Europe, Asia, and Rest of the World. , ... spread through 135 pages and in-depth TOC on ...
Breaking Biology Technology:Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3New Video Shows How to Simplify Cycle Chemistry Sample Panels to Save Time and Costs 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5
... , ... therapeutics company, announces that the first clinical center in the,US, ... the phase III clinical study of Alpharadin in men with,castration-resistant ... the skeleton. , The ALSYMPCA (ALpharadin ...
... Dec. 11 Gwathmey, Inc., a pre-clinical contract ... aureus, and cardiovascular disease announces a new CEO. ... Ph.D., has joined Gwathmey as Chief Executive Officer. ... with small businesses and the federal government. Prior ...
... ... announces the opening of a NEW 2nd North American facility in Marietta, OH. The facility ... the North American market, specifically in the area of New Product Introductions (NPI) for temperature-controlled ... Hatboro, PA ...
Cached Biology Technology:Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2